✨ Free AI Report
KORU Medical Systems, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research KORU Medical Systems, Inc.
Company Research

KORU Medical Systems, Inc.: Business Overview, Financials & Competitive Analysis

KORU Medical Systems is a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions. The company...

Analyst-debate audio for KORU Medical Systems, Inc.

AskCyborg analysts argue the bull and bear cases for KORU Medical Systems, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
6/ 10Solid

Cyborg Score thesis

Growth-stage medical device company demonstrating revenue acceleration and path to profitability with expanding subcutaneous...

Read the full analyst-debate transcript →
Industry Medical Devices - Specialty Drug Delivery Systems
2 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest KORU Medical Systems, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

KORU Medical Systems, Inc. Overview

Pro stress-test →

KORU Medical Systems is a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions. The company offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH).

Strategic Profile

Pro stress-test →

The Freedom System includes the Freedom60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HigH-Flo Subcutaneous Safety Needle Sets™, and received its first FDA clearance in 1994. Through its Novel Therapies business, KORU Medical provides products for use by biopharmaceutical companies in feasibility/clinical trials during the drug development process.

Competitive Landscape

Pro stress-test →

KORU Medical operates in the specialized subcutaneous drug delivery market serving immunodeficiency and rare disease patients. The company competes indirectly with larger medical device manufacturers and specialty pharmaceutical distributors. Analyst consensus rates the company as "Moderate Buy", indicating investor confidence despite its small scale relative to larger peers.

Industry Context

KORU Medical Systems, Inc. operates in Medical Devices - Specialty Drug Delivery Systems.

Key facts

Founded: 1980 · Headquarters: Mahwah, New Jersey, United States · Revenue: $41.1M · Market cap: $219M

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on KORU Medical Systems, Inc..

  • Full year 2025 positive operating cash flow achieved with record revenue growth of 22% year-over-year
  • Recently received FDA 510(k) clearance for delivery of RYSTIGGO® (rozanolixizumab-noli), expanding label for FreedomEDGE® Infusion System
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • January 2026Hired Eric Schiller as Chief Technology Officer with equity incentive grants
  • January 2026Received FDA 510(k) clearance for RYSTIGGO® delivery capability
  • +1 moreTrack every material event for KORU Medical Systems, Inc. as it happens. Explore monitoring →
Get alerted when KORU Medical Systems, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Infusion Pumps and SystemsLarge-scale infusion delivery systems for institutional settings→Home Infusion ServicesIntegrated home infusion therapy providers→

Compare KORU Medical Systems, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

KORU Medical Systems, Inc. operates in Medical Devices - Specialty Drug Delivery Systems. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices - Specialty Drug Delivery Systems research →
NEW · MCP server

Ask your AI assistant about KORU Medical Systems, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare KORU Medical Systems, Inc. and its top competitor on Cyborg Score”
“What did KORU Medical Systems, Inc. do this quarter?”
“Is KORU Medical Systems, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does KORU Medical Systems, Inc. do?+
KORU Medical Systems is a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions. The company...
What is KORU Medical Systems, Inc.'s Cyborg Score?+
KORU Medical Systems, Inc. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are KORU Medical Systems, Inc.'s main competitors?+
Named competitors include Infusion Pumps and Systems, Home Infusion Services. The full competitive landscape is in the AskCyborg report.
How can I get the full KORU Medical Systems, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the KORU Medical Systems, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track KORU Medical Systems, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.